CoinScoopByteDance AI Drug Unit Raises $290 Million at $1.5 Billion Valuation
ByteDance has completed a $290 million funding round for its AI-driven drug discovery unit, achieving a $1.5 billion valuation. This rapid growth reflects increasing investor confidence in AI applications within the pharmaceutical sector.
Summaries are written by AI from the original article. Not investment advice.